Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy. Issue 10 (31st August 2018) - Racil, Zdenek; Koritakova, Eva; Sacha, Tomasz; Klamova, Hana; Belohlavkova, Petra; Faber, Edgar; Rea, Delphine; Malaskova, Ludmila; Prochazkova, Jirina; Zackova, Daniela; Voglova, Jaroslava; Wącław, Joanna; et al.